Substitution therapy-Reference-Cited by-同舟云学术

Substitution therapy

Published:2020-06-19 Issue:S3 Volume:27 Page:53-59
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Shima Midori¹^ORCID,Sidonio Robert F.²

Affiliation:

1. Thrombosis and Hemostasis Research Center Nara Medical University Kashihara Japan

2. Department of Pediatrics Emory University School of Medicine Atlanta GA USA

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.14072

Reference47 articles.

1. A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model

2. Factor VIII–Mimetic Function of Humanized Bispecific Antibody in Hemophilia A

3. Emicizumab treamtnet is efficacious and well tolerated long term in persons with hemophilia A (PwHA) with or without FVIII inhibitors: pooled data from four HAVEN studies;Callaghan M;Int Soc Thromb Haemost,2019

4. Emicizumab Prophylaxis in Hemophilia A with Inhibitors

5. A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of emicizumab in preventing bleeding events in severe and moderate hemophilia A: A single‐center experience in Bangladesh;eJHaem;2024-01-09

2. The use of infrared thermography for non-invasive detection of bleeding and musculoskeletal abnormalities in patients with hemophilia: an observational study;Thrombosis Journal;2023-06-28

3. From a bispecific monoclonal antibody to gene therapy: A new era in the treatment of hemophilia A;Biomedical Papers;2023-03-15

4. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia;Expert Review of Hematology;2023-03-15

5. Achieving access to haemophilia care in low-income and lower-middle-income countries: expanded Humanitarian Aid Program of the World Federation of Hemophilia after 5 years;The Lancet Haematology;2022-09